CANY
ARCT icon

Caxton Associates (New York)’s Arcturus Therapeutics ARCT Stock Holding History

Caxton Associates (New York)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,967
Closed -$202K – 473
2024
Q1 		$202K Buy
+5,967
New +$202K 0.01% 423